When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABCL - AbCellera rises 9% after hours as beneficiary of COVID antibody cocktail EUA expansion
AbCellera Biologics Inc.
Shares of AbCellera Biologics (NASDAQ:ABCL) are up 9% in post-market trading, apparently getting a boost from the FDA Emergency Use Authorization expansion earlier in the day for bamlanivimab and etesevimab, developed with Eli Lilly (NYSE:LLY), for COVID-19. The EUA for the antibody cocktail was expanded to include children under the age of 12. Check out AbCellera's Q3 2021 earnings.